{"id":"intradermal-injection-of-bcg-vaccine","safety":{"commonSideEffects":[{"rate":"null","effect":"Local reaction"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"The intradermal injection of BCG Vaccine induces a localized immune response, which helps to prevent the spread of tuberculosis. This is achieved through the activation of T cells and the production of cytokines, leading to the elimination of infected cells.","oneSentence":"BCG Vaccine works by stimulating the immune system to produce a cell-mediated response against Mycobacterium tuberculosis.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:16:39.143Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Prevention of tuberculosis"}]},"trialDetails":[{"nctId":"NCT03091660","phase":"PHASE3","title":"S1602: Different Strains of BCG With or Without Vaccine in High Grade Non- Muscle Invasive Bladder Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"SWOG Cancer Research Network","startDate":"2017-02-24","conditions":"Stage 0 Bladder Urothelial Carcinoma, Stage 0is Bladder Urothelial Carcinoma, Stage I Bladder Urothelial Carcinoma","enrollment":1000},{"nctId":"NCT05947890","phase":"PHASE2","title":"Evaluating the Safety and Immunogenicity of MTBVAC","status":"RECRUITING","sponsor":"HIV Vaccine Trials Network","startDate":"2024-01-30","conditions":"HIV I Infection, Tuberculosis","enrollment":276},{"nctId":"NCT05591339","phase":"PHASE4","title":"Diabetes Diagnosis, Management, Prevention and Education in Guinea-Bissau","status":"ACTIVE_NOT_RECRUITING","sponsor":"Bandim Health Project","startDate":"2023-12-01","conditions":"Diabetes Mellitus, BCG Vaccination Reaction","enrollment":200},{"nctId":"NCT04658680","phase":"PHASE4","title":"Can BCG Vaccination at First Health-facility Contact Reduce Early Infant Mortality?","status":"ACTIVE_NOT_RECRUITING","sponsor":"Bandim Health Project","startDate":"2021-02-25","conditions":"Infant Mortality, BCG","enrollment":22800},{"nctId":"NCT04453293","phase":"PHASE3","title":"Immunization With BCG Vaccine to Prevent Tuberculosis Infection","status":"TERMINATED","sponsor":"Henry M. Jackson Foundation for the Advancement of Military Medicine","startDate":"2021-12-01","conditions":"Tuberculosis Infection","enrollment":16},{"nctId":"NCT06845358","phase":"PHASE1","title":"Safety and Challenge Study of BCG TICE(R) Vaccination to Test Tuberculosis Immunity in Heathy Humans","status":"WITHDRAWN","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2025-11-26","conditions":"Tuberculosis","enrollment":""},{"nctId":"NCT06670755","phase":"NA","title":"ID93/GLA-SE Vaccination + BCG Challenge","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Oxford","startDate":"2024-12-18","conditions":"Tuberculosis","enrollment":48},{"nctId":"NCT06246851","phase":"NA","title":"BCG Revaccination Study in Diabetic and Non-Diabetic Adults","status":"ENROLLING_BY_INVITATION","sponsor":"University of Oxford","startDate":"2024-04-03","conditions":"Tuberculosis","enrollment":36},{"nctId":"NCT07152639","phase":"PHASE3","title":"Clinical Trial to Evaluate the Efficacy and Safety of EEC for the Diagnosis of Mycobacterium Tuberculosis Infection in People Aged 3 Years and Above","status":"RECRUITING","sponsor":"Chengdu CoenBiotech Co., Ltd","startDate":"2025-08-09","conditions":"Tuberculosis","enrollment":1784},{"nctId":"NCT05507671","phase":"PHASE3","title":"The Role of BCG Vaccine in the Clinical Evolution of COVID-19 and in the Efficacy of Anti-SARS-CoV-2 Vaccines","status":"ACTIVE_NOT_RECRUITING","sponsor":"Oswaldo Cruz Foundation","startDate":"2021-05-27","conditions":"COVID-19","enrollment":556},{"nctId":"NCT07094711","phase":"PHASE2","title":"Safety, Immunogenicity, and Efficacy of Therapeutic Mycobacterium Bovis BCG (BOOST)","status":"NOT_YET_RECRUITING","sponsor":"University of Virginia","startDate":"2025-09-30","conditions":"Mycobacterium Avium-intracellulare Infection, Mycobacterium Infections, Nontuberculous","enrollment":48},{"nctId":"NCT06997367","phase":"PHASE2","title":"Safety and Immunogenicity of a Mycobacterium Tuberculosis Vaccine MTBVAC in Healthy Indian Adults and Adolescents (BBV169/2024)","status":"RECRUITING","sponsor":"Bharat Biotech International Limited","startDate":"2025-03-01","conditions":"Tuberculosis (TB)","enrollment":164},{"nctId":"NCT06078891","phase":"EARLY_PHASE1","title":"Does BCG Vaccination Reduce Biomarkers of Alzheimer's Disease?","status":"ENROLLING_BY_INVITATION","sponsor":"Tamir Ben-Hur","startDate":"2023-07-01","conditions":"Alzheimer Disease, Late Onset","enrollment":60},{"nctId":"NCT04975178","phase":"PHASE3","title":"Efficacy, Safety and Immunogenicity Evaluation of MTBVAC in Newborns in Sub-Saharan Africa","status":"RECRUITING","sponsor":"Biofabri, S.L","startDate":"2022-10-17","conditions":"Tuberculosis","enrollment":7120},{"nctId":"NCT04884308","phase":"PHASE2","title":"Bacille Calmette-Guerin (BCG) Vaccine for Immune Protection Against Infections","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2021-04-28","conditions":"Cystic Fibrosis, Bronchiectasis Adult, Non-Tuberculous Mycobacteria","enrollment":30},{"nctId":"NCT04777721","phase":"PHASE1","title":"Aerosol BCG Challenge Study in Historically BCG-vaccinated Volunteers","status":"COMPLETED","sponsor":"University of Oxford","startDate":"2022-05-17","conditions":"Tuberculosis","enrollment":12},{"nctId":"NCT04538911","phase":"PHASE1","title":"Phase I Clinical Protocol for Pre-evaluation of the Safety of BCG-PPD in Tuberculosis Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.","startDate":"2021-07-02","conditions":"Tuberculosis","enrollment":60},{"nctId":"NCT04806178","phase":"PHASE3","title":"Immunological Response of Bladder Cancer Patients Under BCG","status":"COMPLETED","sponsor":"University of Campinas, Brazil","startDate":"2021-09-03","conditions":"Bladder Cancer, Bacillus Calmette-Guerin","enrollment":30},{"nctId":"NCT06636682","phase":"PHASE2","title":"FK-PC101 as Adjuvant Therapy for Men With High-Risk Prostate Cancer","status":"RECRUITING","sponsor":"Cellvax Therapeutics Inc","startDate":"2024-10-14","conditions":"Prostate Cancer (Adenocarcinoma), Prostate CA, Prostate Cancers","enrollment":100},{"nctId":"NCT04348370","phase":"PHASE4","title":"BCG Vaccine for Health Care Workers as Defense Against COVID 19","status":"COMPLETED","sponsor":"Texas A&M University","startDate":"2020-04-20","conditions":"Coronavirus, Coronavirus Infection, Coronavirus as the Cause of Diseases Classified Elsewhere","enrollment":659},{"nctId":"NCT04327206","phase":"PHASE3","title":"BCG Vaccination to Protect Healthcare Workers Against COVID-19","status":"COMPLETED","sponsor":"Murdoch Childrens Research Institute","startDate":"2020-03-30","conditions":"Coronavirus Disease 2019 (COVID-19), Respiratory Illness, Corona Virus Infection","enrollment":6828},{"nctId":"NCT04542330","phase":"PHASE3","title":"Using BCG to Protect Senior Citizens During the COVID-19 Pandemic","status":"COMPLETED","sponsor":"Bandim Health Project","startDate":"2020-09-15","conditions":"Covid19, Non-specific Effects of Vaccines, Heterologous Immunity","enrollment":1700},{"nctId":"NCT05397678","phase":"PHASE4","title":"Trial to Compare BCG-Bulgaria and BCG-Denmark","status":"UNKNOWN","sponsor":"Bandim Health Project","startDate":"2022-10-21","conditions":"Death; Neonatal, Death, Infant, Morbidity;Newborn","enrollment":15000},{"nctId":"NCT04383925","phase":"PHASE4","title":"Trial to Compare Two Strains of BCG","status":"COMPLETED","sponsor":"Bandim Health Project","startDate":"2020-05-04","conditions":"Death, Infant, Morbidity;Infant","enrollment":16390},{"nctId":"NCT03912207","phase":"PHASE1","title":"Investigating Immune Responses to Aerosol BCG Challenge in Healthy UK Adults","status":"UNKNOWN","sponsor":"University of Oxford","startDate":"2019-04-19","conditions":"Tuberculosis","enrollment":94},{"nctId":"NCT06178666","phase":"NA","title":"A Controlled Human Infection Model (CHIM) With Intradermal BCG in Malawi","status":"UNKNOWN","sponsor":"Liverpool School of Tropical Medicine","startDate":"2024-03-01","conditions":"Tuberculosis","enrollment":30},{"nctId":"NCT05330884","phase":"PHASE3","title":"BCG Revaccination in Children and Adolescents","status":"SUSPENDED","sponsor":"Tuberculosis Research Centre, India","startDate":"2024-07-15","conditions":"Tuberculosis Infection, Tuberculosis","enrollment":9200},{"nctId":"NCT04369794","phase":"PHASE4","title":"COVID-19: BCG As Therapeutic Vaccine, Transmission Limitation, and Immunoglobulin Enhancement","status":"COMPLETED","sponsor":"University of Campinas, Brazil","startDate":"2020-10-01","conditions":"COVID-19, Therapeutic Vaccine, BCG","enrollment":400},{"nctId":"NCT02709278","phase":"PHASE1","title":"Aerosol BCG Challenge Trial in Healthy UK Adults","status":"COMPLETED","sponsor":"University of Oxford","startDate":"2016-03-07","conditions":"Tuberculosis","enrollment":46},{"nctId":"NCT05203068","phase":"NA","title":"Specificity Trial of the Recombinant Tuberculosis Allergen in BCG Vaccinated Healthy Volunteers","status":"COMPLETED","sponsor":"National Medical Research Center of Phthisiopulmonology and Infectious Diseases","startDate":"2021-11-24","conditions":"Tuberculosis","enrollment":150},{"nctId":"NCT05820594","phase":"NA","title":"Using BCG Vaccine to Understand Tuberculosis Infection","status":"UNKNOWN","sponsor":"Liverpool School of Tropical Medicine","startDate":"2023-06-30","conditions":"Tuberculosis","enrollment":30},{"nctId":"NCT04563273","phase":"PHASE1","title":"Clinical Study of BCG Vaccine for Intradermal Injection","status":"COMPLETED","sponsor":"Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.","startDate":"2020-10-21","conditions":"Tuberculosis","enrollment":160},{"nctId":"NCT05004038","phase":"PHASE2","title":"BCG Vaccination Effect on Latent Reservoir Size in Treated HIV-1 Infection:","status":"UNKNOWN","sponsor":"University of Zurich","startDate":"2022-01-04","conditions":"HIV-1-infection","enrollment":60},{"nctId":"NCT05468606","phase":"EARLY_PHASE1","title":"Coadministration of GA2 Sporozoites With Adjuvants","status":"UNKNOWN","sponsor":"Leiden University Medical Center","startDate":"2023-02-03","conditions":"Malaria,Falciparum","enrollment":45},{"nctId":"NCT04641858","phase":"PHASE4","title":"BCG to Reduce Absenteeism Among Health Care Workers During the COVID-19 Pandemic","status":"COMPLETED","sponsor":"University of Southern Denmark","startDate":"2020-12-03","conditions":"Covid19, Morbidity, Absenteeism","enrollment":668},{"nctId":"NCT03947138","phase":"PHASE3","title":"A Study of GC3107(BCG Vaccine) in Healthy Infants","status":"COMPLETED","sponsor":"Green Cross Corporation","startDate":"2019-08-06","conditions":"BCG Vaccination Reaction, Tuberculosis","enrollment":750},{"nctId":"NCT00070070","phase":"PHASE1","title":"Vaccine Therapy in Treating Patients With Transitional Cell Carcinomas","status":"COMPLETED","sponsor":"Ludwig Institute for Cancer Research","startDate":"2003-10-28","conditions":"Transitional Cell Carcinoma","enrollment":6},{"nctId":"NCT04537663","phase":"PHASE4","title":"Prevention Of Respiratory Tract Infection And Covid-19 Through BCG Vaccination In Vulnerable Older Adults","status":"COMPLETED","sponsor":"UMC Utrecht","startDate":"2020-09-07","conditions":"Respiratory Tract Infections, Covid19","enrollment":6112},{"nctId":"NCT05124340","phase":"PHASE2","title":"Safety and Tuberculin Conversion Following BCG Vaccination","status":"COMPLETED","sponsor":"PT Bio Farma","startDate":"2021-12-01","conditions":"BCG Vaccination Reaction","enrollment":220},{"nctId":"NCT04938323","phase":"PHASE2, PHASE3","title":"Prevention of Acute Respiratory Infection in Taiwanese Institutionalized Elderly","status":"WITHDRAWN","sponsor":"Harvard Medical School (HMS and HSDM)","startDate":"2022-05","conditions":"Acute Respiratory Infection","enrollment":""},{"nctId":"NCT04439045","phase":"PHASE3","title":"Efficacy and Safety of VPM1002 in Reducing SARS-CoV-2 (COVID-19) Infection Rate and Severity","status":"COMPLETED","sponsor":"University Health Network, Toronto","startDate":"2020-06-24","conditions":"SARS-CoV-2 Infection","enrollment":122},{"nctId":"NCT04593771","phase":"PHASE1","title":"Phase I Clinical Protocol of BCG-PPD in Healthy People","status":"COMPLETED","sponsor":"Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.","startDate":"2020-10-21","conditions":"Tuberculosis","enrollment":80},{"nctId":"NCT02504203","phase":"PHASE4","title":"Can Earlier BCG Vaccination Reduce Early Infant Mortality? A Randomised Trial","status":"TERMINATED","sponsor":"Bandim Health Project","startDate":"2015-11","conditions":"Infant Mortality, BCG","enrollment":2332},{"nctId":"NCT04379336","phase":"PHASE3","title":"BCG Vaccination for Healthcare Workers in COVID-19 Pandemic","status":"COMPLETED","sponsor":"TASK Applied Science","startDate":"2020-05-04","conditions":"COVID-19, Sars-CoV2","enrollment":1000},{"nctId":"NCT04449926","phase":"PHASE2","title":"BCG and Plasma Amyloid in Non-Demented Adults","status":"COMPLETED","sponsor":"Mindful Diagnostics and Therapeutics, LLC","startDate":"2020-11-09","conditions":"Alzheimer Disease, Late Onset","enrollment":49},{"nctId":"NCT04435379","phase":"PHASE3","title":"Study to Assess VPM1002 in Reducing Hospital Admissions and/or Severe Respiratory Infectious Diseases in Elderly in COVID-19 Pandemic","status":"COMPLETED","sponsor":"Serum Life Science Europe GmbH","startDate":"2020-06-18","conditions":"Infection, Respiratory Tract","enrollment":2038},{"nctId":"NCT04373291","phase":"PHASE3","title":"Using BCG Vaccine to Protect Health Care Workers in the COVID-19 Pandemic","status":"COMPLETED","sponsor":"Bandim Health Project","startDate":"2020-05-18","conditions":"COVID-19, Non-specific Effects of Vaccines, Morbidity","enrollment":1293},{"nctId":"NCT04534803","phase":"PHASE3","title":"BCG Against Covid-19 for Prevention and Amelioration of Severity Trial (BAC to the PAST)","status":"WITHDRAWN","sponsor":"Harvard Medical School (HMS and HSDM)","startDate":"2021-09","conditions":"Covid19","enrollment":""},{"nctId":"NCT04414267","phase":"PHASE4","title":"Bacillus Calmette-guérin Vaccination to Prevent COVID-19","status":"COMPLETED","sponsor":"Hellenic Institute for the Study of Sepsis","startDate":"2020-05-26","conditions":"COVID-19, Virus Diseases, Corona Virus Infection","enrollment":301},{"nctId":"NCT02712424","phase":"PHASE2","title":"DAR-901 TB Booster Vaccine to Prevent TB in Adolescents","status":"COMPLETED","sponsor":"Dartmouth-Hitchcock Medical Center","startDate":"2016-03","conditions":"Tuberculosis","enrollment":625},{"nctId":"NCT04632537","phase":"PHASE3","title":"BCG Vaccination to Prevent COVID-19","status":"WITHDRAWN","sponsor":"Henry M. Jackson Foundation for the Advancement of Military Medicine","startDate":"2020-12-07","conditions":"COVID-19","enrollment":""},{"nctId":"NCT03296423","phase":"PHASE4","title":"Bacillus Calmette-guérin Vaccination to Prevent Infections of the Elderly","status":"COMPLETED","sponsor":"Hellenic Institute for the Study of Sepsis","startDate":"2017-09-21","conditions":"Infection, Hospitalization, Mortality","enrollment":200},{"nctId":"NCT03400878","phase":"PHASE4","title":"Comparing Morbidity and Mortality Effects of Two Different Strains of BCG","status":"COMPLETED","sponsor":"Bandim Health Project","startDate":"2017-10-14","conditions":"Heterologous Immunity, Infant Morbidity, Infant Mortality","enrollment":17505},{"nctId":"NCT02447536","phase":"PHASE4","title":"Trial of Two Strains of BCG","status":"COMPLETED","sponsor":"Bandim Health Project","startDate":"2014-12-08","conditions":"Morbidity, Bacille Calmette-Guérin","enrollment":12006},{"nctId":"NCT03213405","phase":"PHASE1","title":"A Study to Assess Safety, Tolerability and Immunogenicity of the Live Attenuated hRSV Vaccine rBCG-N-hRSV","status":"COMPLETED","sponsor":"Pontificia Universidad Catolica de Chile","startDate":"2017-06-27","conditions":"Respiratory Syncytial Virus Infections","enrollment":24},{"nctId":"NCT04648800","phase":"PHASE3","title":"Clinical Trial Evaluating the Effect of BCG Vaccination on the Incidence and Severity of SARS-CoV-2 Infections Among Healthcare Professionals During the COVID-19 Pandemic in Poland","status":"UNKNOWN","sponsor":"Hanna Czajka","startDate":"2020-07-07","conditions":"Covid19, BCG Vaccination Reaction, SARS-CoV Infection","enrollment":1000},{"nctId":"NCT04362124","phase":"PHASE3","title":"Performance Evaluation of BCG Vaccination in Healthcare Personnel to Reduce the Severity of COVID-19 Infection.","status":"WITHDRAWN","sponsor":"Universidad de Antioquia","startDate":"2020-08","conditions":"COVID-19","enrollment":""},{"nctId":"NCT04387409","phase":"PHASE3","title":"Study to Assess VPM1002 in Reducing Healthcare Professionals' Absenteeism in COVID-19 Pandemic","status":"UNKNOWN","sponsor":"Serum Life Science Europe GmbH","startDate":"2020-05-25","conditions":"Infection, Respiratory Tract","enrollment":59},{"nctId":"NCT04384549","phase":"PHASE3","title":"Efficacy of BCG Vaccination in the Prevention of COVID19 Via the Strengthening of Innate Immunity in Health Care Workers","status":"UNKNOWN","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2020-05-20","conditions":"Infection, Viral, Agent as Cause of Disease Classified Elsewhere","enrollment":1120},{"nctId":"NCT04350931","phase":"PHASE3","title":"Application of BCG Vaccine for Immune-prophylaxis Among Egyptian Healthcare Workers During the Pandemic of COVID-19","status":"UNKNOWN","sponsor":"Ain Shams University","startDate":"2020-04-20","conditions":"Coronavirus Disease (COVID-19)","enrollment":900},{"nctId":"NCT00396370","phase":"PHASE1","title":"BCG Vaccination Delivered Intradermally, Orally and by Combined Routes","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2008-12-02","conditions":"Tuberculosis","enrollment":69},{"nctId":"NCT03175380","phase":"EARLY_PHASE1","title":"Biological Samples Obtained by Leukapheresis Induced by Two BCG Vaccinations in BCG-naïve Healthy Adults in the US","status":"COMPLETED","sponsor":"Aeras","startDate":"2017-08-08","conditions":"Tuberculosis","enrollment":15},{"nctId":"NCT01231503","phase":"PHASE2","title":"Safety and Immunogenicity of GSK Biologicals' Malaria Vaccine 257049 When Administered on 7 Schedules to African Infants","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2011-01-13","conditions":"Malaria","enrollment":480},{"nctId":"NCT03363178","phase":"PHASE1","title":"Study to Investigate the Safety and Efficacy of GC3107 (BCG Vaccine) in Healthy Adults","status":"UNKNOWN","sponsor":"Green Cross Corporation","startDate":"2017-12-14","conditions":"Tuberculosis","enrollment":20},{"nctId":"NCT02769923","phase":"NA","title":"ID Administration of fIPV Using Intradermal Adapters vs. BCG Syringe","status":"COMPLETED","sponsor":"Aga Khan University","startDate":"2015-09","conditions":"IPV","enrollment":450},{"nctId":"NCT02444611","phase":"NA","title":"A Trial Investigating the Influence of BCG and Hepatitis B Immunisation at Birth on Neonatal Immune Responses: The Early Life Vaccines and Immunity Study","status":"COMPLETED","sponsor":"Murdoch Childrens Research Institute","startDate":"2015-03","conditions":"Innate Immune Response","enrollment":185},{"nctId":"NCT01694108","phase":"PHASE4","title":"Bacille Calmette Guérin Immunisation at Birth and Childhood Morbidity in Danish Children.","status":"COMPLETED","sponsor":"Lone Graff Stensballe","startDate":"2012-09","conditions":"Prospective, Single-blind, Clinical","enrollment":4262},{"nctId":"NCT01742364","phase":"NA","title":"Comparative Study of Bacille Calmette Guerin (BCG) Delivery Via Disposable Syringe Jet Injector and Needle & Syringe","status":"COMPLETED","sponsor":"PATH","startDate":"2012-12","conditions":"Tuberculosis","enrollment":96},{"nctId":"NCT01119521","phase":"PHASE1","title":"Study of Pre-clearance of Latent Tuberculosis Infection And BCG Revaccination","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2010-10","conditions":"Tuberculosis","enrollment":82},{"nctId":"NCT02380508","phase":"NA","title":"Heterologous Effects of BCG in Healthy UK Adults","status":"COMPLETED","sponsor":"University of Oxford","startDate":"2015-02","conditions":"Tuberculosis","enrollment":36},{"nctId":"NCT02771782","phase":"PHASE4","title":"Influence of BCG on TDaP-IPV Vaccination","status":"UNKNOWN","sponsor":"Radboud University Medical Center","startDate":"2015-01","conditions":"Whooping Cough","enrollment":75},{"nctId":"NCT00568854","phase":"NA","title":"Immunobiology of Diabetes and Tuberculosis","status":"TERMINATED","sponsor":"Stanford University","startDate":"2007-04","conditions":"Tuberculosis, Diabetes Mellitus","enrollment":10},{"nctId":"NCT02063555","phase":"PHASE1","title":"Phase I Trial of DAR-901","status":"COMPLETED","sponsor":"Dartmouth-Hitchcock Medical Center","startDate":"2014-02","conditions":"Tuberculosis","enrollment":59},{"nctId":"NCT00477906","phase":"PHASE3","title":"M-Vax + Low Dose Interleukin-2 Versus Placebo Vaccine in Metastatic Melanoma in Patients With Stage IV Melanoma","status":"UNKNOWN","sponsor":"AVAX Technologies","startDate":"2016-07","conditions":"Melanoma","enrollment":387},{"nctId":"NCT01650389","phase":"PHASE2","title":"Safety and Immunogenicity of MVA85A Prime and Bacille Calmette-Guerin Boost Vaccination","status":"COMPLETED","sponsor":"Mark Hatherill","startDate":"2012-10","conditions":"Tuberculosis, HIV","enrollment":248},{"nctId":"NCT02085590","phase":"PHASE2, PHASE3","title":"Effects of BCG on Immune Response","status":"COMPLETED","sponsor":"Radboud University Medical Center","startDate":"2014-03","conditions":"Sepsis","enrollment":20},{"nctId":"NCT02088892","phase":"NA","title":"A Clinical Challenge Study of BCG in Healthy Volunteers","status":"COMPLETED","sponsor":"University of Oxford","startDate":"2014-03","conditions":"Tuberculosis","enrollment":52},{"nctId":"NCT01879163","phase":"PHASE1","title":"Phase I Trial Evaluating Safety and Immunogenicity of MVA85A-IMX313 Compared to MVA85A in BCG Vaccinated Adults","status":"COMPLETED","sponsor":"University of Oxford","startDate":"2013-07","conditions":"Tuberculosis (TB)","enrollment":30},{"nctId":"NCT01683773","phase":"PHASE1","title":"Safety Study of Tuberculosis Vaccines AERAS-402 and MVA85A","status":"COMPLETED","sponsor":"University of Oxford","startDate":"2012-09","conditions":"Tuberculosis","enrollment":40},{"nctId":"NCT01497769","phase":"PHASE1","title":"Safety of Tuberculosis Vaccine, MVA85A, Administered by the Aerosol Route and the Intradermal Route","status":"COMPLETED","sponsor":"University of Oxford","startDate":"2011-09","conditions":"Tuberculosis","enrollment":24},{"nctId":"NCT01013623","phase":"PHASE3","title":"Stage IV Surgery Versus Best Medical Therapy","status":"TERMINATED","sponsor":"Saint John's Cancer Institute","startDate":"2009-11","conditions":"Stage IV Resectable Melanoma","enrollment":12},{"nctId":"NCT01194180","phase":"PHASE1","title":"A BCG Challenge Model Study to Assess Anti-mycobacterial Immunity Induced by BCG and a Candidate TB Vaccine, MVA85A","status":"COMPLETED","sponsor":"University of Oxford","startDate":"2010-05","conditions":"Tuberculosis","enrollment":48},{"nctId":"NCT01250249","phase":"PHASE3","title":"A Study of Comparing Safety and Reactogenicity, of Lyophilized BCG Vaccine IP of Green Signal Bio Pharma Private Limited, India With BCG Vaccine of Serum Institute of India Limited in 120 Healthy Children.","status":"COMPLETED","sponsor":"Green Signal Biopharma Private Limited","startDate":"2008-11","conditions":"Healthy","enrollment":120},{"nctId":"NCT00037713","phase":"PHASE3","title":"Survival in a Randomized Phase III Trial in Patients With Limited Disease (LD) Small Cell Lung Cancer Vaccinated With Adjuvant BEC2 and BCG","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"1998-09","conditions":"Carcinoma, Small Cell Lung","enrollment":515},{"nctId":"NCT00480454","phase":"PHASE1","title":"Safety, Immunogenicity, and Impact of MVA85A, on the Immunogenicity of the EPI Vaccines","status":"COMPLETED","sponsor":"University of Oxford","startDate":"2006-10","conditions":"TB","enrollment":214},{"nctId":"NCT00331474","phase":"PHASE1, PHASE2","title":"The Effect of Bacille Calmette Guerin (BCG) Vaccination on Immune Responses in HIV-Exposed and Unexposed Infants","status":"UNKNOWN","sponsor":"University of Stellenbosch","startDate":"2006-05","conditions":"HIV Infections","enrollment":180},{"nctId":"NCT00654316","phase":"PHASE1","title":"Study of the Safety and Immunogenicity of Bacille Calmette Guerin (BCG) Vaccine","status":"COMPLETED","sponsor":"University of Oxford","startDate":"2004-02","conditions":"TB","enrollment":11},{"nctId":"NCT00242047","phase":"PHASE4","title":"Randomized Controlled Trial of Percutaneous and Intradermal BCG Vaccination.","status":"UNKNOWN","sponsor":"University of Cape Town","startDate":"2001-03","conditions":"Tuberculosis","enrollment":12000}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"intradermal injection of BCG Vaccine","genericName":"intradermal injection of BCG Vaccine","companyName":"Ain Shams University","companyId":"ain-shams-university","modality":"Biologic","firstApprovalDate":"","aiSummary":"BCG Vaccine works by stimulating the immune system to produce a cell-mediated response against Mycobacterium tuberculosis. Used for Prevention of tuberculosis.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}